Published • loading... • Updated
What to Know About HMPV, the Respiratory Virus with No Cure Surging Across the US
The CDC reports widespread HMPV infections with no antiviral treatments, affecting young children, older adults, and immunocompromised people during typical winter-spring circulation.
- WastewaterSCAN data indicated high HMPV concentrations in San Francisco, Sacramento, and Napa, while officials in New Jersey reported elevated positivity for the virus at emergency rooms across the state.
- HMPV, a virus in the same family as RSV, spreads through close personal contact, coughing, or touching contaminated surfaces, according to the U.S. Centers for Disease Control and Prevention.
- Symptoms typically include cough, fever, and shortness of breath; the CDC reports the virus "can cause upper and lower respiratory illness" that may progress to pneumonia or bronchitis.
- While there are no targeted antivirals for HMPV, most patients recover with rest and fluids, though young children, older adults, and those with weakened immune systems face risks for severe disease.
- The CDC emphasizes good hand hygiene and covering coughs to prevent infection, especially within schools and childcare settings, noting that travel typically does not amplify these community-associated infections.
Insights by Ground AI
29 Articles
29 Articles
Human Metapneumovirus Spreads Across US With No Cure Or Vaccine
A respiratory virus that currently lacks a specific cure or vaccine is moving through the United States, prompting health officials to monitor its rapid spread. Known as human metapneumovirus (HMPV), the infection is primarily transmitted through respiratory droplets and contaminated surfaces. While most people experience mild, cold-like symptoms, the virus is now being detected at “high” levels in wastewater across the country. Data from the CD…
Coverage Details
Total News Sources29
Leaning Left0Leaning Right0Center27Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
